Contact Information
Selina Chen-Kiang, Ph.D.
Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College
Our goal is to understand the mechanism for cell cycle control of immunity and hematologic malignancies and to translate this knowledge into novel cell cycle-based cancer therapy. Following our discovery that CDK4/CDK6 control B cell immunity, we are investigating CDK control of cancer metabolism and defining genes that mediate clinical response to our hypothesis- driven therapy targeting CDK4/CDK6 in lymphoma and myeloma.
PI: Selina Chen-Kiang, Ph.D.
National Cancer Institute
PI: Selina Chen-Kiang, Ph.D.
The Leukemia & Lymphoma Society Mantle Cell Lymphoma Research Initiative
PI: Selina Chen-Kiang, Ph.D.
National Cancer Institute
PI: Selina Chen-Kiang, Ph.D.
American Society of Hematology Bridge Grant
Selina Chen-Kiang, Ph.D.
Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College